ANAVEX LIFE SCIENCES CORP. Other Receivables
ANAVEX LIFE SCIENCES CORP. (AVXL) had Other Receivables of $800.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Notes › Nontrade Receivables
us-gaap:OtherReceivables · last filed 2026-08-28
- 2026-06-30: Other Receivables $800.00K.
- 2026-03-31: Other Receivables $800.00K.
- 2025-12-31: Other Receivables $700.00K.
- 2025-09-30: Other Receivables $700.00K.
| Period end | Other Receivables |
|---|---|
| 2026-06-30 | $800.00K 10-Q · filed 2026-08-28 |
| 2026-03-31 | $800.00K 10-Q · filed 2026-08-28 |
| 2025-12-31 | $700.00K 10-Q · filed 2026-02-09 |
| 2025-09-30 | $700.00K 10-K/A · filed 2026-08-28 |
| 2025-06-30 | $600.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $500.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $2.40M 10-Q · filed 2025-02-12 |
| 2024-09-30 | $2.30M 10-K/A · filed 2026-08-28 |
| 2023-09-30 | $2.50M 10-K · filed 2024-12-23 |
| 2022-09-30 | $2.90M 10-K · filed 2023-11-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |